Literature DB >> 15057956

Prenatal diagnosis and management of sex chromosome aneuploidy: a report on 98 cases.

Jean-Luc Brun1, Flore Gangbo, Zon Qi Wen, Katia Galant, Laurence Taine, Brigitte Maugey-Laulom, Denis Roux, Raphaelle Mangione, Jacques Horovitz, Robert Saura.   

Abstract

OBJECTIVES: To analyse the management of pregnancy after prenatal diagnosis of sex chromosome aneuploidy (SCA) and the factors influencing genetic counselling and parental decision.
METHODS: Between 1991 and 2001, 73 non-mosaic fetal SCA were diagnosed in our centre and 25 were referred to us from outside institutions. The same geneticist carried out genetic counselling. The outcome of pregnancies and the termination trend over time were determined according to the type of SCA. Clinical parental data were analysed in order to assess whether they influenced genetic counselling.
RESULTS: 45,X was diagnosed in 41 fetuses. The main indication for karyotyping was abnormal ultrasound (83%). The termination rate was 93%. Sex chromosome polysomies (SCP) including 47,XXY, 47,XXX, and 47,XYY were diagnosed in 31, 16, and 10 fetuses respectively. The main indication for karyotyping was advanced maternal age (60%). The termination rate was 32, 25, and 20% respectively. The difference between the termination rate for local cases (25%) and referred cases (33%) was not significant. The termination rate for pregnancies with SCP was 38% in 1991 to 1994, 34% in 1995 to 1998, and 12% in 1999 to 2001. The parents' characteristics did not influence the outcome of pregnancy.
CONCLUSIONS: The relatively low termination rate (28%) in pregnancies where the fetus was affected by SCP and the decreasing termination trend over time in our centre suggest an improved knowledge of the pathological conditions associated with SCP, influencing genetic counselling. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15057956     DOI: 10.1002/pd.834

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy.

Authors:  Patricia Anne Boyd; Maria Loane; Ester Garne; Babak Khoshnood; Helen Dolk
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

2.  Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities.

Authors:  Anne Hawkins; Ana Stenzel; Joanne Taylor; Valerie Y Chock; Louanne Hudgins
Journal:  J Genet Couns       Date:  2012-09-23       Impact factor: 2.537

3.  Parental decisions regarding a prenatally detected fetal chromosomal abnormality and the impact of genetic counseling: an analysis of 38 cases with aneuploidy in Southeast Turkey.

Authors:  Mahmut Balkan; Sevgi Kalkanli; Halit Akbas; Ahmet Yalinkaya; M Nail Alp; Turgay Budak
Journal:  J Genet Couns       Date:  2010-01-30       Impact factor: 2.537

Review 4.  A review of trisomy X (47,XXX).

Authors:  Nicole R Tartaglia; Susan Howell; Ashley Sutherland; Rebecca Wilson; Lennie Wilson
Journal:  Orphanet J Rare Dis       Date:  2010-05-11       Impact factor: 4.123

5.  Population-based Assessment of Cardiometabolic-related Diagnoses in Youth With Klinefelter Syndrome: A PEDSnet Study.

Authors:  Shanlee M Davis; Natalie J Nokoff; Anna Furniss; Laura Pyle; Anna Valentine; Patricia Fechner; Chijioke Ikomi; Brianna Magnusen; Leena Nahata; Maria G Vogiatzi; Amanda Dempsey
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

6.  Socioeconomic inequalities in pregnancy outcome associated with Down syndrome: a population-based study.

Authors:  Judith L S Budd; Elizabeth S Draper; Robyn R Lotto; Laura E Berry; Lucy K Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-06-12       Impact factor: 5.747

7.  Lack of consensus in the choice of termination of pregnancy for Turner syndrome in France.

Authors:  Monika Hermann; Babak Khoshnood; Olivia Anselem; Claire Bouvattier; Aurélie Coussement; Sophie Brisset; Alexandra Benachi; Vassilis Tsatsaris
Journal:  BMC Health Serv Res       Date:  2019-12-23       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.